The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.
The global Addictions Therapeutics market was valued at US$ 4745.6 million in 2023 and is anticipated to reach US$ 6401.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Addictions Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Addictions Therapeutics.
Report Scope
The Addictions Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Addictions Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Addictions Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Alkermes Plc
- Amneal Pharmaceuticals Inc.
- Indivior Plc
- Johnson & Johnson Services Inc.
- Mylan NV
- Novartis AG
- Novo Nordisk AS
- Opiant Pharmaceuticals Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Segment by Type
- Alcohol Addiction Therapeutics
- Tobacco Addiction Therapeutics
- Drug Addiction Therapeutics
Segment by Application
- Public
- Private
- Government
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Addictions Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Addictions Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Alcohol Addiction Therapeutics
1.2.3 Tobacco Addiction Therapeutics
1.2.4 Drug Addiction Therapeutics
1.3 Market by Application
1.3.1 Global Addictions Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Public
1.3.3 Private
1.3.4 Government
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Addictions Therapeutics Market Perspective (2019-2030)
2.2 Addictions Therapeutics Growth Trends by Region
2.2.1 Global Addictions Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Addictions Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Addictions Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Addictions Therapeutics Market Dynamics
2.3.1 Addictions Therapeutics Industry Trends
2.3.2 Addictions Therapeutics Market Drivers
2.3.3 Addictions Therapeutics Market Challenges
2.3.4 Addictions Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Addictions Therapeutics Players by Revenue
3.1.1 Global Top Addictions Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Addictions Therapeutics Revenue
3.4 Global Addictions Therapeutics Market Concentration Ratio
3.4.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2023
3.5 Addictions Therapeutics Key Players Head office and Area Served
3.6 Key Players Addictions Therapeutics Product Solution and Service
3.7 Date of Enter into Addictions Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Addictions Therapeutics Breakdown Data by Type
4.1 Global Addictions Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2025-2030)
5 Addictions Therapeutics Breakdown Data by Application
5.1 Global Addictions Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Addictions Therapeutics Market Size (2019-2030)
6.2 North America Addictions Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Addictions Therapeutics Market Size by Country (2019-2024)
6.4 North America Addictions Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Addictions Therapeutics Market Size (2019-2030)
7.2 Europe Addictions Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Addictions Therapeutics Market Size by Country (2019-2024)
7.4 Europe Addictions Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Addictions Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Addictions Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Addictions Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Addictions Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Addictions Therapeutics Market Size (2019-2030)
9.2 Latin America Addictions Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Addictions Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Addictions Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Addictions Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Addictions Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Addictions Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Addictions Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes Plc
11.1.1 Alkermes Plc Company Detail
11.1.2 Alkermes Plc Business Overview
11.1.3 Alkermes Plc Addictions Therapeutics Introduction
11.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2019-2024)
11.1.5 Alkermes Plc Recent Development
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Detail
11.2.2 Amneal Pharmaceuticals Inc. Business Overview
11.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction
11.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2019-2024)
11.2.5 Amneal Pharmaceuticals Inc. Recent Development
11.3 Indivior Plc
11.3.1 Indivior Plc Company Detail
11.3.2 Indivior Plc Business Overview
11.3.3 Indivior Plc Addictions Therapeutics Introduction
11.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2019-2024)
11.3.5 Indivior Plc Recent Development
11.4 Johnson & Johnson Services Inc.
11.4.1 Johnson & Johnson Services Inc. Company Detail
11.4.2 Johnson & Johnson Services Inc. Business Overview
11.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction
11.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2019-2024)
11.4.5 Johnson & Johnson Services Inc. Recent Development
11.5 Mylan NV
11.5.1 Mylan NV Company Detail
11.5.2 Mylan NV Business Overview
11.5.3 Mylan NV Addictions Therapeutics Introduction
11.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2019-2024)
11.5.5 Mylan NV Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Addictions Therapeutics Introduction
11.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2019-2024)
11.6.5 Novartis AG Recent Development
11.7 Novo Nordisk AS
11.7.1 Novo Nordisk AS Company Detail
11.7.2 Novo Nordisk AS Business Overview
11.7.3 Novo Nordisk AS Addictions Therapeutics Introduction
11.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2019-2024)
11.7.5 Novo Nordisk AS Recent Development
11.8 Opiant Pharmaceuticals Inc.
11.8.1 Opiant Pharmaceuticals Inc. Company Detail
11.8.2 Opiant Pharmaceuticals Inc. Business Overview
11.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction
11.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2019-2024)
11.8.5 Opiant Pharmaceuticals Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Detail
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Addictions Therapeutics Introduction
11.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2019-2024)
11.9.5 Pfizer Inc. Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2019-2024)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
